前哨淋巴結陽性的乳腺癌患者腋窩放療或手術--eortcamaros試驗的最終分析-資料下載頁
2025-11-29 07:47本頁面
【正文】 Ljubljana, Univ Hosp, Slovenia Lille, Centre Oscar Lambret, France Geneva, Hosp Cantonal, Swiss Nijmegen, UMC St Radbout, the Netherlands Grenoble, CHUG Grenoble, France Gdansk, Medical Univ, Poland Roermond, Laurentius ZH, the Netherlands Den Haag, Bronovo ZH, the Netherlands Groningen, UMCG, the Netherlands Hardenberg, R246。pckeZweers ZH, the Netherlands Den Haag, Haga ZH, the Netherlands Cardiff, Univ Hosp Wales, United Kingdom Manchester, Manchester Univ Hosp, United Kingdom Torino, San Giovanni Battista Hosp, Italy Apeldoorn, Gelre ZH, the Netherlands Eindhoven, Catharina ZH, the Netherlands Amstelveen, Amstelland ZH, the Netherlands Delft, R de Graaf GH, the Netherlands Haarlem, Kennemer GH, the Netherlands Istanbul, Marmara Univ Hosp, Turkey Haifa, Rambam Med Center, Israel Paris, Inst Curie, France 謝謝 Form pliance % valid forms received 1 year 2 years 3 years 5 years lymphedema Shoulder function Quality of Life ? 操作 : 用反射性核素 必須 ? “前哨淋巴結陽性”的定義 : 至少 1個腋窩前哨淋巴結陽性 陽性 :宏轉移 /微轉移 /孤立癌細胞 ? 質量控制 : 學習階段需要 ≥ 30 前哨淋巴結 前哨淋巴結活檢 * ITC only excluded from AxSN+ group since April 2022 無遠處轉移生存 HR:。 95%CI: P= 淋巴水腫 : 手臂周長 前臂 上臂 Years after randomization Years after randomization 生命質量 *Question 19 from the BR23 module, item of the ‘Arm symptom’ scale. 趨勢傾向于腋窩放療后有更多手臂運動障礙 生命質量 趨勢傾向于腋窩淋巴結清掃術后有更多水腫 *Question 18 from the BR23 module, item of the ‘Arm symptom’ scale
教學課件相關推薦
鄂ICP備17016276號-1